Drug General Information
Drug ID
D05STL
Former ID
DNCL002012
Drug Name
ARRY-502
Indication Allergic asthma [ICD9: 493, 995.3; ICD10:J45, T78.4] Phase 2 [523846]
Company
Array BioPharma
Structure
Download
2D MOL

3D MOL

Target and Pathway
Target(s) Putative G-protein coupled receptor 44 Target Info Modulator [550275]
Reactome Prostanoid ligand receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 523846ClinicalTrials.gov (NCT01561690) A Study of ARRY-502 in Patients With Persistent Asthma. U.S. National Institutes of Health.
Ref 550275Clinical pipeline report, company report or official report of Array BioPharma (Drug: ARRY-502).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.